Viewing StudyNCT04751383



Ignite Creation Date: 2024-05-06 @ 3:47 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04751383
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-11
First Post: 2021-02-11

Brief Title: Testing the Combination of Two Immunotherapy Drugs Magrolimab and Dinutuximab in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Sponsor:
Organization: National Cancer Institute NCI